ARANESP 500 ug/mL
darbepoetin alfa · INJECTION, SOLUTION · Amgen, Inc
ARANESP is a injection, solution containing darbepoetin alfa at 500 ug/mL, taken intravenous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- ARANESP
- Generic Name
- darbepoetin alfa
- NDC Code (Product)
55513-032- Manufacturer
- Amgen, Inc
- Strength
- 500 ug/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103951
- Drug Class
- Erythropoiesis-stimulating Agent [EPC]
- Marketing Start
- 06/07/2006
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is ARANESP used for?
ARANESP contains darbepoetin alfa. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is ARANESP a controlled substance?
ARANESP is not classified as a controlled substance by the DEA.
What is the generic name for ARANESP?
The generic name for ARANESP is darbepoetin alfa. There are no other listed brand versions of darbepoetin alfa.
What is the NDC code for ARANESP 500 ug/mL?
The NDC (National Drug Code) for ARANESP 500 ug/mL is 55513-032, listed by Amgen, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)